Tech Company Financing Transactions
GenePOC Funding Round
On 1/15/2015, GenePOC landed investment from Debiopharm Diagnostics and Emerillon Capital.
Transaction Overview
Company Name
Announced On
1/15/2015
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Debiopharm Diagnostics (Lead Investor) (David Deperthes)
Emerillon Capital (Ludovic André)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
360 rue Franquet
Quebec QC, G1P 4N3
Canada
Quebec QC, G1P 4N3
Canada
Phone
Website
Email Address
Overview
GenePOC Inc. is a privately owned company that develops cost-effective and rapid molecular devices to detect genes at Point-of-Care. GenePOC has developed a simple and integrated portable instrument for the prevention and early detection of infectious diseases based on a unique centripetal technology platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Patrice Allibert
Founder
Michel Bergeron
VP - Finance
Marie-Josée Paré
VP - Manufacturing
Jean Côté
VP - R & D
Sébastien Chapdelaine
VP - Regulatory Affairs
Dany Leblanc
VP - Sales
Michael Blitz
Browse more venture capital transactions:
Prev: 1/15/2015: IRX Therapeutics venture capital transaction
Next: 1/15/2015: Sense360 venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs